Allarta Life Science

Allarta Life Science

Edit info

  • Founded: 2018
  • Location: Hamilton, ON
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Diabetes (1)
  • Drug types: END, IMM, ONC, RAR, HEM, NEU, CVV
  • Lead product: Undisclosed
  • Funding: <10M


allarta.com

linkedin.com

job board


Business:

Cell Therapies & Biologics

Drug notes:

Additional undisclosed programs RD oncology, lysosomal disorders, rare blood disorders, neurodegenerative disorders, cardiometabolic disorders, inflammation, sesnor coatings

About:

Allarta Life Science is advancing regenerative medicine approaches to create cell and stem cell therapies. Allarta’s proprietary platform is geared to create safe, durable and retrievable stem cell therapies. To achieve this, Allarta is focusing on three technologies: [1] Proprietary immune-privileged polymers, [2] next-generation microgels and [3] RT-Vaccine delivery. Technology improvement involves developing, synthesizing and characterizing novel polymers and materials that can enable cell encapsulation, facilitate cell attachment, assess immune protection or for cryoprotection. Allarta is initially developing their technology for diabetes and lysosomal storage disorders with the pipeline in preclinical studies.

Post a job


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com